The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Leadership - MediWeb
ENGOT-OV44/FIRST study: a randomized, double-blind, adaptive, phase III study of standard of care (SOC) platinum-based therapy ± dostarlimab followed by niraparib ± dostarlimab maintenance as first-line (1L) treatment of stage 3 or 4 ovarian cancer (OC).
 
Anne-Claire Hardy-Bessard
Consulting or Advisory Role - AstraZeneca; Novartis; Pfizer; Roche; Tesaro
Travel, Accommodations, Expenses - Roche; Tesaro
 
Kathleen N. Moore
Honoraria - Prime Oncology; Research To Practice
Consulting or Advisory Role - Abbvie; Aravive; AstraZeneca (Inst); Clovis Oncology; Eisai; Genentech/Roche; Immunogen; Janssen Oncology; Merck; Mersana (Inst); OncoMed; Pfizer/EMD Serono; Samumed; TESARO (Inst); Vavotar Life Sciences; VBL Therapeutics
Research Funding - Abbvie/Stemcentrx (Inst); Advaxis (Inst); Agenus (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Forty Seven (Inst); Genentech (Inst); Immunogen (Inst); Lilly (Inst); Lilly Foundation (Inst); Merck (Inst); Novartis Pharmaceuticals UK Ltd. (Inst); Novogen (Inst); PTC Therapeutics (Inst); Regeneron (Inst); Stem CentRx (Inst); Takeda (Inst); Tesaro (Inst); Verastem (Inst)
 
Mansoor Raza Mirza
Leadership - Karyopharm Therapeutics; SeraCare
Stock and Other Ownership Interests - Karyopharm Therapeutics; SeraCare
Honoraria - Advaxis; AstraZeneca; Cerulean Pharma; Clovis Oncology; Novocure; Pfizer; Roche; tesaro
Consulting or Advisory Role - AstraZeneca; BioCad; Cerulean Pharma; Clovis Oncology; Genmab; Karyopharm Therapeutics; Novocure; Pfizer; Sotio; Tesaro
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Pfizer (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Karyopharm Therapeutics; Pfizer; Roche; SeraCare; Tesaro
 
Bernard Asselain
Honoraria - AstraZeneca; Ipsen; Roche; SERVIER
 
Andres Redondo
Consulting or Advisory Role - Amgen; AstraZeneca; Clovis Oncology; GlaxoSmithKline; PharmaMar; Roche
Research Funding - Eisai (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca; PharmaMar; Roche
 
Jacobus Pfisterer
Honoraria - Amgen; AstraZeneca; Clovis Oncology; MSD Oncology; Roche Pharma AG; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; MSD Oncology; Roche Pharma AG; Tesaro
Research Funding - Roche Pharma AG (Inst); Roche Pharma AG (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - Roche Pharma AG; Tesaro
 
Sandro Pignata
Honoraria - AstraZeneca; MSD; pfizer; pharmamar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Pfizer; PharmaMar; Roche; tesaro
Research Funding - AstraZeneca (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Diane M. Provencher
Leadership - AstraZeneca
Honoraria - AstraZeneca; Roche/Genentech
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - Roche/Genentech
 
David Cibula
Consulting or Advisory Role - AstraZeneca; Roche; Sotio
 
Anna K.L. Reyners
No Relationships to Disclose
 
Lubomir Bodnar
Honoraria - Ipsen; Roche
 
Rosalind Glasspool
Honoraria - Clovis Oncology
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Clovis Oncology; Clovis Oncology; Clovis Oncology; immunogen; Roche; Sotio; Tesaro; Tesaro; Tesaro
Research Funding - AstraZeneca (Inst); Boehringer Ingelheim (Inst); Clovis Oncology (Inst); Ignyta (Inst); Immunogen (Inst); Pfizer (Inst); Roche (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Roche; TESARO
 
Christos Papadimitriou
Honoraria - Amgen; AstraZeneca; Genesis Pharma; Merck; MSD; Novartis; Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Genesis Pharma; Merck; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; Roche
Expert Testimony - Bristol-Myers Squibb; Roche
 
Rami Eitan
No Relationships to Disclose
 
Sileny N. Han
No Relationships to Disclose
 
Linda R. Duska
Consulting or Advisory Role - CUE Biopharma; Genentech/Roche; Inovio Pharmaceuticals; Merck; Morphotek; Tesaro
Research Funding - Abbvie (Inst); Aduro Biotech (Inst); Advaxis (Inst); Aeterna Zentaris (Inst); Bristol-Myers Squibb (Inst); Cerulean Pharma (Inst); Cerulean Pharma (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Leap Therapeutics (Inst); Ludwig Institute for Cancer Research (Inst); Merck (Inst); Millennium (Inst); Morab (Inst); Morphotek (Inst); Novartis (Inst); Pfizer (Inst); Syndax (Inst); Syndax (Inst); Tesaro (Inst)
 
BJ Rimel
Honoraria - Genentech
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Deep 6 AI; Genentech/Roche; Tesaro
 
Gupta Divya
Employment - GlaxoSmithKline
 
Jian Chen
Employment - GlaxoSmithKline
 
Eric Pujade-Lauraine
Honoraria - AstraZeneca; GlaxoSmithKline; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Incyte; Merck; Pfizer/EMD Serono; Roche; TESARO
Travel, Accommodations, Expenses - AstraZeneca; Roche; Tesaro
Other Relationship - Arcagy-Gineco